查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475912

乳房植入物市場：依產品類型、最終用戶、地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031 年

Breast Implants Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 172 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

該報告對全球乳房植入物市場進行了全面分析，深入瞭解市場趨勢、成長動力和課題以及新興機會。這份研究報告對市場進行了深入研究，提供了揭示 2024 年至 2031 年市場軌蹟的關鍵統計數據和預測。

重要見解

  • 乳房植入物市場規模（2024年）：14.821億美元
  • 市場預測（2031年）：20.034億美元
  • 全球市場成長率（2024-2031年複合年增長率）：4.39%

乳房假體市場：調查範圍

乳房植入物市場包括用於隆乳、乳房重建和美容的手術植入物。這些植入物包括矽膠填充植入物、鹽水填充植入物和黏性矽膠植入物，以滿足各種患者的需求和偏好。該市場為整形外科中心、醫院和美容診所提供創新的植入解決方案，增強乳房美觀度並提高患者滿意度。

市場驅動因素：

全球乳房植入物市場由幾個關鍵成長因素推動。美學意識的提高，加上不斷變化的美容標準和生活方式偏好，正在推動對隆乳和假體增強的需求。植入物設計、材料科學和手術技術的技術進步降低了併發症的風險，並有助於開發更安全、外觀更自然的植入物。此外，可支配收入的增加、醫療保健基礎設施的擴大和醫療旅遊業的擴大正在推動市場成長，使不同人群更容易獲得乳房植入物。

市場限制因素：

儘管成長前景廣闊，但乳房植入物市場面臨安全問題、監管監督和公眾認知的課題。與某些植入物類型相關的安全問題，包括破裂、包膜攣縮和植入物移位等風險，增加了患者和醫療保健提供者的焦慮，並影響了市場需求和採用率。此外，監管環境的變化，例如 FDA 對某些植入設備的重新分類以及對上市後監督的加強，要求製造商採取合規措施和風險管理策略，從而增加了市場環境的複雜性。

市場機會：

由於技術創新、病患教育和市場擴張舉措，乳房植入物市場提供了利潤豐厚的機會。個人化植入選擇、3D 列印技術和仿生植入等新興趨勢提供了根據患者個體解剖結構和美學偏好量身定制的解決方案，提高了患者滿意度並改善了臨床結果。此外，微創手術和脂肪移植技術等外科技術的進步正在擴大豐胸手術的範圍，以滿足不同患者的需求。此外，植入物製造商、整形外科醫生和患者支持組織之間的策略合作促進了宣傳活動、患者支持服務和教育資源，以培養對隆乳和重建手術的正面看法。

本報告解決的關鍵問題

  • 推動全球乳房假體市場成長的關鍵因素是什麼？
  • 技術進步和病人偏好如何影響乳房植入物產品和手術的演變？
  • 隆乳和重建領域的市場參與者面臨的主要課題和機會是什麼？
  • 哪些地區和醫療保健環境為乳房植入物製造商和整形外科中心提供最大的成長潛力？
  • 在乳房美容手術和重建的競爭格局中，領先公司採取哪些策略來提高產品創新、市場滲透率和病患治療效果？

競爭資訊與經營策略：

全球乳房植入物市場的領導企業，包括跨國醫療器材公司、整形外科中心和美容診所，都專注於技術創新、病人安全和市場擴張，以保持競爭力。這些公司投資研發，開發符合監管標準和臨床最佳實踐的下一代種植技術、手術技術和以患者為中心的護理途徑。此外，與關鍵意見領袖、專業協會和監管機構的策略合作夥伴關係加速了產品開發、臨床證據產生和市場開發工作，以加速乳房植入手術的採用和報銷。此外，注重病患教育、知情同意和上市後監測可確保持續的安全監測和風險緩解，增強對乳房植入物產品和服務的信任和信心。

主要公司簡介：

  • Allergan, Plc (Actavis Plc)
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

乳房植入物市場細分

依產品類型

  • 矽膠乳房植入物
  • 生理食鹽水乳房植入物

依用途

  • 整容手術
  • 重建手術

依形狀

  • 圓形植入物
  • 解剖型乳房植入物

由最終用戶

  • 醫院
  • 美容診所

依地區

  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲 (MEA)

目錄

第一章內容提要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包容與排除

第三章市場動態

  • 宏觀經濟因素
  • 促進因素
    • 供給側驅動因素
    • 需求方驅動因素
  • 抑制因素
  • 機會
  • 趨勢

第 4 章主要內容

  • 監管場景
  • 退款場景
  • 產品概覽
  • 價格分析

第五章全球乳房植入物市場價值分析

  • 過往市值分析（2019-2023）
  • 目前和未來的市值預測（2024-2031）
    • 同比增長趨勢分析
    • 絕對量機會分析

第六章全球乳房植入物市場分析：依產品類型

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依產品類型
  • 依產品類型劃分的當前和未來市場規模分析和預測（2024-2031）
    • 矽膠乳房植入物
    • 生理食鹽水乳房植入物
  • 依產品類型分析市場吸引力

第七章全球乳房植入物市場分析：依形狀

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依形狀
  • 目前與未來的市場規模分析與預測（2024-2031）：依形狀
    • 圓形乳房假體
    • 解剖型乳房植入物
  • 依形狀劃分的市場吸引力分析

第八章全球乳房植入物市場分析：依應用分類

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依應用
  • 目前和未來的市場規模分析和預測（2024-2031）：依應用分類
    • 整容手術
    • 重建手術
  • 依應用劃分的市場吸引力分析

第九章全球乳房植入物市場分析：依最終用戶分類

  • 簡介/主要發現
  • 過去的市場規模分析（2019-2023）：依最終用戶
  • 最終用戶當前和未來的市場規模分析和預測（2024-2031）
    • 醫院
    • 美容診所
  • 最終用戶的市場吸引力分析

第10章全球乳房植入物市場分析：依地區

  • 介紹
  • 過去的市場規模分析（2019-2023）：依地區
  • 依地區劃分的當前和未來市場規模分析和預測（2024-2031）
    • 北美
    • 拉丁美洲
    • 歐洲
    • 亞太地區
    • 中東/非洲
  • 依地區劃分的市場吸引力分析

第十一章北美乳房植入物市場分析

第十二章拉丁美洲乳房植入物市場

第十三章歐洲乳房植入物市場

第十四章亞太地區乳房植入物市場

第十五章中東和非洲的乳房植入物市場

第 16 章 競爭分析

  • 比賽儀表板
  • 衝突詳情
    • Allergan, Plc（Actavis Plc）
    • Mentor Worldwide LLC.（Johnson &Johnson Services, Inc.）
    • GC Aesthetics plc
    • Sientra, Inc.,
    • Groupe Sebbin SAS
    • Polytech Health & Aesthetics GmbH
    • Establishment Labs SA
    • HansBiomed Co., Ltd
    • CEREPLAS

第 17 章假設與縮寫

第18章研究方法論

簡介目錄
Product Code: PMRREP10972

Persistence Market Research offers a comprehensive analysis of the global Breast Implants Market, providing insights into market trends, growth drivers, challenges, and emerging opportunities. This study presents a detailed examination of the market, furnishing crucial statistics and projections delineating the market's trajectory from 2024 to 2031.

Key Insights:

  • Breast Implants Market Size (2024): USD 1,482.1 Million
  • Projected Market Value (2031): USD 2,003.4 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.39%

Breast Implants Market - Report Scope:

The Breast Implants Market encompasses a range of surgical implants used for breast augmentation, breast reconstruction, and cosmetic enhancements. These implants include silicone gel-filled implants, saline-filled implants, and cohesive silicone gel implants, catering to diverse patient needs and preferences. The market serves plastic surgery centers, hospitals, and cosmetic clinics, offering innovative implant solutions to enhance breast aesthetics and improve patient satisfaction.

Market Growth Drivers:

The global Breast Implants Market is driven by several key growth factors. Increasing aesthetic awareness, coupled with changing beauty standards and lifestyle preferences, fuels demand for breast augmentation procedures and implant-based enhancements. Technological advancements in implant design, material science, and surgical techniques contribute to the development of safer, more natural-looking implants with reduced risks of complications. Moreover, rising disposable incomes, expanding healthcare infrastructure, and growing medical tourism drive market growth, enabling greater accessibility to breast implant procedures across diverse demographic segments.

Market Restraints:

Despite promising growth prospects, the Breast Implants Market faces challenges related to safety concerns, regulatory scrutiny, and public perception. Safety issues associated with certain implant types, including risks of rupture, capsular contracture, and implant displacement, raise apprehensions among patients and healthcare providers, impacting market demand and adoption rates. Furthermore, regulatory changes, such as the FDA's reclassification of certain implant devices and heightened scrutiny of post-market surveillance, necessitate compliance measures and risk management strategies for manufacturers, adding complexity to the market landscape.

Market Opportunities:

The Breast Implants Market presents lucrative opportunities driven by technological innovation, patient education, and market expansion initiatives. Emerging trends such as personalized implant options, 3D printing technologies, and bioengineered implants offer customizable solutions tailored to individual patient anatomy and aesthetic preferences, enhancing patient satisfaction and clinical outcomes. Additionally, advancements in surgical techniques, including minimally invasive approaches and fat grafting procedures, expand the scope of breast enhancement procedures and address diverse patient needs. Moreover, strategic collaborations between implant manufacturers, plastic surgeons, and patient advocacy groups promote awareness campaigns, patient support services, and educational resources, fostering a positive perception of breast augmentation and reconstruction procedures.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Implants Market globally?
  • How are technological advancements and patient preferences shaping the evolution of breast implant products and procedures?
  • What are the key challenges and opportunities facing market participants in the breast augmentation and reconstruction segment?
  • Which geographic regions and healthcare settings offer the highest growth potential for breast implant manufacturers and plastic surgery centers?
  • What strategies are leading companies employing to enhance product innovation, market penetration, and patient outcomes in the competitive landscape of breast aesthetics and reconstruction?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Implants Market, including multinational medical device companies, plastic surgery centers, and aesthetic clinics, focus on innovation, patient safety, and market expansion to maintain a competitive edge. These companies invest in research and development to develop next-generation implant technologies, surgical techniques, and patient-centered care pathways aligned with regulatory standards and clinical best practices. Moreover, strategic partnerships with key opinion leaders, professional societies, and regulatory authorities facilitate product development, clinical evidence generation, and market access initiatives, driving adoption and reimbursement for breast implant procedures. Furthermore, emphasis on patient education, informed consent, and post-market surveillance ensures ongoing safety monitoring and risk mitigation, reinforcing trust and confidence in breast implant products and services.

Key Companies Profiled:

  • Allergan, Plc (Actavis Plc)
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Breast Implants Market Segmentation

By Product Type

  • Silicone Breast Implants
  • Saline Breast Implants

By Application

  • Cosmetic Surger
  • Reconstructive Surgery

By Shape

  • Round Breast Implants
  • Anatomical Breast Implants

By End User

  • Hospitals
  • Cosmetology Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunities
  • 3.5. Trends

4. Key Inclusion

  • 4.1. Regulatory Scenario
  • 4.2. Reimbursement Scenario
  • 4.3. Product Overview
  • 4.4. Pricing Analysis

5. Global Breast Implants Market Value Analysis 2019-2023 and Forecast, 2024-2031

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Global Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2023 - 2024
    • 6.3.1. Silicone Breast Implants
    • 6.3.2. Saline Breast Implants
  • 6.4. Market Attractiveness Analysis By Product Type

7. Global Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Shape

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Shape, 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Shape, 2023 - 2024
    • 7.3.1. Round Breast Implants
    • 7.3.2. Anatomical Breast Implants
  • 7.4. Market Attractiveness Analysis By Shape

8. Global Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023 - 2024
    • 8.3.1. Cosmetic Surgery
    • 8.3.2. Reconstructive surgery
  • 8.4. Market Attractiveness Analysis By Application

9. Global Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023 - 2024
    • 9.3.1. Hospitals
    • 9.3.2. Cosmetic Clinics
  • 9.4. Market Attractiveness Analysis By End User

10. Global Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023 - 2024
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia-Pacific
    • 10.3.5. Middle East & Africa
  • 10.4. Market Attractiveness Analysis By Region

11. North America Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product Type
    • 11.3.3. By Shape
    • 11.3.4. By Application
    • 11.3.5. By End User
  • 11.4. Market Attractiveness Analysis
  • 11.5. Drivers and Restraints - Impact Analysis

12. Latin America Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Rest of Latin America
    • 12.3.2. By Product Type
    • 12.3.3. By Shape
    • 12.3.4. By Application
    • 12.3.5. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. Europe Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. U.K.
      • 13.3.1.3. France
      • 13.3.1.4. Italy
      • 13.3.1.5. Spain
      • 13.3.1.6. Poland
      • 13.3.1.7. Russia
      • 13.3.1.8. Rest of Europe
    • 13.3.2. By Product Type
    • 13.3.3. By Shape
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers and Restraints - Impact Analysis

14. Asia-Pacific Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. India
      • 14.3.1.3. Japan
      • 14.3.1.4. Australia & New Zealand
      • 14.3.1.5. South Korea
      • 14.3.1.6. Rest of Asia-Pacific
    • 14.3.2. By Product Type
    • 14.3.3. By Shape
    • 14.3.4. By Application
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. Middle East and Africa Breast Implants Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. GCC Countries
      • 15.3.1.2. South Africa
      • 15.3.1.3. Rest of MEA
    • 15.3.2. By Product Type
    • 15.3.3. By Shape
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. Competition Analysis

  • 16.1. Competition Dashboard
  • 16.2. Competition Deep Dive
    • 16.2.1. Allergan, Plc (Actavis Plc)
      • 16.2.1.1. Company Overview
      • 16.2.1.2. Segment Overview
      • 16.2.1.3. Product Offerings
      • 16.2.1.4. Financial Analysis
      • 16.2.1.5. Key Developments
      • 16.2.1.6. Strategy Overview
    • 16.2.2. Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
      • 16.2.2.1. Company Overview
      • 16.2.2.2. Segment Overview
      • 16.2.2.3. Product Offerings
      • 16.2.2.4. Financial Analysis
      • 16.2.2.5. Key Developments
      • 16.2.2.6. Strategy Overview
    • 16.2.3. GC Aesthetics plc
      • 16.2.3.1. Company Overview
      • 16.2.3.2. Segment Overview
      • 16.2.3.3. Product Offerings
      • 16.2.3.4. Financial Analysis
      • 16.2.3.5. Key Developments
      • 16.2.3.6. Strategy Overview
    • 16.2.4. Sientra, Inc.,
      • 16.2.4.1. Company Overview
      • 16.2.4.2. Segment Overview
      • 16.2.4.3. Product Offerings
      • 16.2.4.4. Financial Analysis
      • 16.2.4.5. Key Developments
      • 16.2.4.6. Strategy Overview
    • 16.2.5. Groupe Sebbin SAS
      • 16.2.5.1. Company Overview
      • 16.2.5.2. Segment Overview
      • 16.2.5.3. Product Offerings
      • 16.2.5.4. Financial Analysis
      • 16.2.5.5. Key Developments
      • 16.2.5.6. Strategy Overview
    • 16.2.6. Polytech Health & Aesthetics GmbH
      • 16.2.6.1. Company Overview
      • 16.2.6.2. Segment Overview
      • 16.2.6.3. Product Offerings
      • 16.2.6.4. Financial Analysis
      • 16.2.6.5. Key Developments
      • 16.2.6.6. Strategy Overview
    • 16.2.7. Establishment Labs S.A.
      • 16.2.7.1. Company Overview
      • 16.2.7.2. Segment Overview
      • 16.2.7.3. Product Offerings
      • 16.2.7.4. Financial Analysis
      • 16.2.7.5. Key Developments
      • 16.2.7.6. Strategy Overview
    • 16.2.8. HansBiomed Co., Ltd
      • 16.2.8.1. Company Overview
      • 16.2.8.2. Segment Overview
      • 16.2.8.3. Product Offerings
      • 16.2.8.4. Financial Analysis
      • 16.2.8.5. Key Developments
      • 16.2.8.6. Strategy Overview
    • 16.2.9. CEREPLAS
      • 16.2.9.1. Company Overview
      • 16.2.9.2. Segment Overview
      • 16.2.9.3. Product Offerings
      • 16.2.9.4. Financial Analysis
      • 16.2.9.5. Key Developments
      • 16.2.9.6. Strategy Overview

17. Assumptions and Acronyms Used

18. Research Methodology